Effects of Lactic Acid Bacteria in Patients With Attention-Deficit/Hyperactivity Disorder
Key facts
- Who runs it
- I-Ching Chou
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 80 people, planned
- Started
- 25 Feb 2026
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional
- Treatments tested
- postbiotics
- Record updated
- 27 February 2026
Who can take part
- Age
- 6 years to 13 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 6-13 years old
- Has been diagnosed with ADHD and is taking medication regularly or has not yet started medication
Who cannot take part
- Have taken antibiotics within one month or are receiving antibiotic treatment
- Those who are allergic to lactic acid bacteria products
- Have used probiotic products in powder, capsule or tablet form within one month (including yogurt, yogurt, Yakult and other related foods)
- Obtain a disability certificate
- Participating in other human research
- Determined unsuitable by the investigator
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 6 and 13 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study aims to evaluate whether postbiotics supplementation can improve ADHD symptoms, such as mood and sleep, in children. Furthermore, salivary biochemical profiles will be analyzed and dietary habits will be recorded to further explore the effects and mechanisms of action of postbiotics.
Read full original descriptionShow less
Research process: 80 subjects who meet the admission conditions will be recruited within three years after IRB approval. They will take the research capsules (postbiotics) in an open label design study and complete the 8-week intervention plus 4 weeks follow up trial period.
The group in the trial
- PostbioticsTreatment being tested
Dietary Supplement
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07419659, who can take part
- Record updated
- 27 February 2026